rs144060489
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_014254.3(RXYLT1):c.1091A>C(p.Asn364Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000235 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014254.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RXYLT1 | NM_014254.3 | c.1091A>C | p.Asn364Thr | missense_variant | Exon 6 of 6 | ENST00000261234.11 | NP_055069.1 | |
| RXYLT1 | NM_001278237.2 | c.311A>C | p.Asn104Thr | missense_variant | Exon 6 of 6 | NP_001265166.1 | ||
| RXYLT1 | XM_047428078.1 | c.782A>C | p.Asn261Thr | missense_variant | Exon 5 of 5 | XP_047284034.1 | ||
| RXYLT1-AS1 | NR_126167.1 | n.557T>G | non_coding_transcript_exon_variant | Exon 4 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251368 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74484 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 364 of the RXYLT1 protein (p.Asn364Thr). This variant is present in population databases (rs144060489, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with RXYLT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 423360). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RXYLT1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
A variant of uncertain significance has been identified in the TMEM5 gene. The N364T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The N364T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, the N364T variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Inborn genetic diseases Uncertain:1
The c.1091A>C (p.N364T) alteration is located in exon 6 (coding exon 6) of the TMEM5 gene. This alteration results from a A to C substitution at nucleotide position 1091, causing the asparagine (N) at amino acid position 364 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at